MedTrace Logo

High-Intensity Focused Ultrasound Ablation in Treating Patients With Localized Prostate Cancer

NCT00561314 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2013-08-26

No results posted yet for this study

Summary

RATIONALE: Highly focused ultrasound energy may be able to kill tumor cells by heating the tumor without affecting the surrounding tissue.

PURPOSE: This phase II trial is studying the side effects and how well highly focused ultrasound energy works in treating patients with localized prostate cancer.

Conditions

Interventions

OTHER

questionnaire administration

PROCEDURE

biopsy

PROCEDURE

high-intensity focused ultrasound ablation

PROCEDURE

magnetic resonance imaging

PROCEDURE

quality-of-life assessment

Sponsors & Collaborators

  • University College London Hospitals

    lead OTHER

Principal Investigators

  • Mark Emberton, MD, FRCS, MBBS · University College London Hospitals

Study Design

Purpose
TREATMENT

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2009-02-28
Completion
2012-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00561314 on ClinicalTrials.gov